Biogen Idec Inc (BIIB)

BIIB (NASDAQ:Drugs)
$332.89
pos +0.00
+0.00%
Today's Range: 0.00 - 0.00 | BIIB Avg Daily Volume: 1,640,100
Last Update: 12/17/14 - 4:00 PM EST
Volume: 0
YTD Performance: 19.07%
Open: $0.00
Previous Close: $332.89
52 Week Range: $270.62 - $358.89
Oustanding Shares: 236,155,407
Market Cap: 76,781,207,478
6-Month Chart
TheStreet Ratings Grade for BIIB
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 11 10 10 11
Moderate Buy 1 1 1 1
Hold 5 5 6 5
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.65 1.69 1.76 1.65
Latest Dividend: 0.00
Latest Dividend Yield: 0.00%
Dividend Ex-Date: 12/31/69
Price Earnings Ratio: 30.79
Price Earnings Comparisons:
BIIB Sector Avg. S&P 500
30.79 30.80 24.82
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
1.62% 22.61% 201.83%
GROWTH 12 Mo 3 Yr CAGR
Revenue 32.60 0.47 0.14
Net Income 34.90 1.07 0.27
EPS 35.70 0.97 0.25
Earnings for BIIB:
EBITDA 1.90B
Revenue 5.81B
Average Earnings Estimates
Qtr (12/14) Qtr (03/15) FY (12/14) FY (12/15)
Average Estimate $3.74 $3.83 $13.47 $16.67
Number of Analysts 2 1 2 2
High Estimate $3.79 $3.83 $13.51 $16.77
Low Estimate $3.69 $3.83 $13.42 $16.56
Prior Year $2.33 $2.45 $8.93 $13.47
Growth Rate (Year over Year) 60.52% 56.33% 50.78% 23.77%
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands
Reams of stocks make sense on a pullback. And what looks bad? Anything even remotely connected to oil and gas.
A litany of reasons why you should calm your nerves.
An immense market rotation is happening.
In this era of turmoil, investors can take comfort in this sector.
It's amazing how stupid the market really is.
Still, it's a good time to review what's happening, so we never forget.
Some growth leaders in the sector are getting technical support.
Bearish
Oct 23, 2014 | 6:43 AM EDT
Shares of BIIB now seen reaching $407, according to Nomura. Estimates also reduced, as Avonex is facing increased competition. Buy rati...
Use one short and one buy.
Update
Sep 08, 2014 | 7:12 AM EDT
Morgan Stanley Healthcare Conference

Columnist Conversations

Today will be my last webinar of 2014. I will talk about some recent trading activity and give you a peek int...
There was a string of good news out of Germany recently. The latest is that the business confidence indicator,...
AAPL needs to clear this hurdle IF this last low is any good!! View Chart » ...
The Fed didn't raise interest rates, but the market did via lower bond and note prices. The recent run in Trea...

REAL MONEY'S BEST IDEAS

Columnist Tweets

BROKERAGE PARTNERS

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.